Advertisement

Ads Placeholder
Loading...

Deinove SA

ALDEI.PAEURONEXT
Healthcare
Biotechnology
0.03
0.00(0.00%)
U.S. Market opens in 55h 54m

Deinove SA (ALDEI.PA) Stock Overview

Explore Deinove SA’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.1M
P/E Ratio-0.11
EPS (TTM)$-0.24
ROE0.61%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ALDEI.PA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Deinove SA (ALDEI.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.11 and a market capitalization of 1.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
11.81%
6-Month Change
-83.82%
Year-to-Date (YTD) Change
26.79%
1-Year Change
-93.40%
3-Year Change
-97.15%
5-Year Change
-98.74%
All-Time (Max) Change
-99.67%

Contact Information

33 4 48 19 01 00
Cap Sigma, Grabels, NaN, 34790

Company Facts

440 Employees
IPO DateApr 21, 2010
CountryFR

Frequently Asked Questions